EP2192987B1 - Dispositif et procédé de traitement de liquides avec des particules magnétiques - Google Patents
Dispositif et procédé de traitement de liquides avec des particules magnétiques Download PDFInfo
- Publication number
- EP2192987B1 EP2192987B1 EP08804473.0A EP08804473A EP2192987B1 EP 2192987 B1 EP2192987 B1 EP 2192987B1 EP 08804473 A EP08804473 A EP 08804473A EP 2192987 B1 EP2192987 B1 EP 2192987B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- magnetic particles
- central element
- magnetic
- liquid
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006249 magnetic particle Substances 0.000 title claims description 101
- 239000007788 liquid Substances 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 28
- 230000005291 magnetic effect Effects 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003302 ferromagnetic material Substances 0.000 claims description 2
- 239000002907 paramagnetic material Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 230000005293 ferrimagnetic effect Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 description 15
- 238000000265 homogenisation Methods 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000013076 target substance Substances 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000007885 magnetic separation Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002023 somite Anatomy 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- -1 RNA Chemical class 0.000 description 1
- 108020004688 Small Nuclear RNA Proteins 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002902 ferrimagnetic material Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/005—Pretreatment specially adapted for magnetic separation
- B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0332—Component parts; Auxiliary operations characterised by the magnetic circuit using permanent magnets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0335—Component parts; Auxiliary operations characterised by the magnetic circuit using coils
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/286—Magnetic plugs and dipsticks disposed at the inner circumference of a recipient, e.g. magnetic drain bolt
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
Definitions
- the present invention relates to an apparatus and a method for treating liquids with magnetic particles.
- the device and the method are suitable, for example, for applications in biochemistry, clinical chemistry, molecular biology, microbiology, medical diagnostics or forensic medicine.
- the basic principle of magnetic separation of substances from complex mixtures is based on the fact that magnetic particles e.g. by chemical treatment of their surface with specific binding properties for the target substances to be separated.
- the size of such magnetic particles is generally in the range from approximately 0.05 to 500 ⁇ m, so that they provide a large surface for the binding reaction.
- the magnetic particles can have a density that is similar to the density of the liquid in which they are suspended. In this case, sedimentation of the magnetic particles can take a few hours.
- the magnetic particles are immobilized at one point by using magnetic forces or a magnetic field, for example by means of a permanent magnet.
- This accumulation of magnetic particles is also referred to as a pellet or magnetic sediment.
- the liquid supernatant is then separated off and discarded, for example by suction or decanting. Since the magnetic particles are immobilized by the magnetic forces, magnetic particles are largely prevented from being separated off together with the supernatant.
- the immobilized magnetic particles are typically subsequently resuspended.
- An elution liquid or an elution buffer is used to enrich the bound target substances.
- the bond between the target substance and the magnetic particles are released and the target substance molecules are released from the magnetic particles.
- the target substance molecules can then be separated together with the elution liquid, while the magnetic particles are immobilized by the action of a magnetic field.
- the target substance molecules can not only be enriched, but also concentrated.
- One or more washing steps can be carried out before the elution step.
- the magnetic rod attracts the magnetic particles so that the magnetic particles adhere to the rod.
- the magnetic rod together with the magnetic particles adhering to it, is then pulled out of the reaction vessel and introduced into a second reaction vessel. There the magnetic force of the rod is then reduced or switched off, so that the magnetic particles detach from the rod and are suspended in a liquid in the reaction vessel. Similar procedures are also out of the US 6,065,605 and the WO 2005/005049 known.
- EP 0 965 842 a device is known in which the magnetic particles are drawn up together with the liquid in which they are suspended in a pipette.
- the pipette tip has a special separation area that can be acted upon by a magnet with a magnetic field. This turns the magnetic particles into pellets or magnetic sediments immobilized on the inside of the pipette tip.
- the aspirated liquid is then removed from the pipette tip by the pipetting function of the device.
- the magnetic field in the separation area can then be removed again, as a result of which the magnetic particles immobilized in the pellet are released again.
- a similar method and a similar device are in the US 6,187,270 described.
- the magnetic particles remain in the same reaction vessel while the liquid in this vessel is exchanged.
- the magnetic sediments can be immobilized at a desired height on the side wall of the reaction vessel in order to adapt to a respective process step. This is done by providing magnets which are arranged on different arms of a rotatably mounted carrier at different distances from the axis of rotation. By rotating the carrier, a specific arm - and thus a specific magnet - can be brought near the side wall of the reaction vessel. At this point, the magnetic particles are then immobilized as a pellet.
- WO 2007/063174-A describes an enrichment unit for biological components in which a magnetic rod is inserted through an opening into a bag.
- WO 99/42832-A describes a method for transferring magnetic particles with the aid of a magnet inserted into a vessel from the outside.
- WO 2004/035217-A describes a method for metering magnetic particles with the aid of a magnet inserted into a vessel from the outside.
- WO 03/072531-A1 describes an apparatus and a method for obtaining magnetic particles in a slurry phase reactor, in which the magnetic particles suspended in a liquid are guided past magnetic bars.
- the present invention is based on the object of overcoming the disadvantages arising from the prior art and, in particular, of creating a device and a method for a wide range of applications in which the treatment of liquids with magnetic particles is possible in a simple manner is.
- a device for treating a liquid with magnetic particles comprising a vessel containing the liquid and a multiplicity of magnetic particles arranged in the liquid and at least one rod-shaped, dumbbell-shaped and / or ellipsoid-shaped magnetic and / or magnetizable central element , wherein the ratio of the longest diameter d2 of the at least one central element to the ratio of the average diameter dl of the magnetic particles at least d 2nd mm ⁇ 15 ⁇ d 1 mm , the central element being located completely inside the vessel, the device additionally comprising at least one external magnet which is designed to interact with the at least one central element, so that the central element can be moved by the external magnet.
- central element is understood in particular to mean any object which is capable of acting through the action of a magnetic field - possibly under the action of a further “external” magnet (as described below) - to bind at least the majority of the magnetic particles to itself in the idle state.
- the at least one central element comprises a magnet, preferably a permanent magnet; According to an alternative, preferred embodiment of the invention, the at least one central element comprises a magnetizable material, such as e.g. Iron.
- liquids is understood to mean, but not limited to, in particular aqueous solutions, suspensions and / or two-phase emulsions with water as a phase which contain biomolecules.
- treatment in the sense of the present invention means in particular that certain biomolecules can attach to the magnetic particles in a separation step; however, the present invention is expressly not limited to this.
- diameter of the magnetic particles means in particular if the magnetic particles are not spherical or essentially spherical, the longest diameter of the magnetic particles in each case.
- average diameter means in particular the arithmetic mean of the diameter of the magnetic particles, which can be measured in particular (but not limited to) on a sample basis.
- the ratio of the longest diameter d2 of the at least one central element to the ratio of the average diameter d1 of the magnetic particles is advantageously d2 (mm) 50 50 ⁇ d1 (mm), more preferably d2 (mm) ⁇ 100 ⁇ d1 (mm), further preferably d2 (mm) ⁇ 200 ⁇ d1 (mm), and most preferably d2 (mm) ⁇ 300 ⁇ d1 (mm).
- the number of magnetic particles per central element is ⁇ 10 4 , advantageously up to ⁇ 10 8 , preferably ⁇ 5 x 10 5 to ⁇ 5 x 10 6 .
- the magnetic particles contain a material selected from the group consisting of paramagnetic materials, superparamagnetic materials, ferromagnetic materials, ferrimagnetic materials and mixtures thereof.
- the average saturation magnetization of the magnetic particles is advantageously ⁇ 1 Am 2 / kg and 250 Am 2 / kg, preferably ⁇ 10 Am 2 / kg and 240 Am 2 / kg, and most preferably ⁇ 20 Am 2 / kg and 235 Am 2 / kg kg. This has been found to be advantageous for many applications of the present invention.
- the at least one central element is rod-shaped, dumbbell-shaped and / or ellipsoid-shaped and the ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b ⁇ 1.1 to a / b ⁇ 10.
- the ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b 1.5 1.5 to a / b 8 8, preferably a / b 2 2 to a / b 5 5.
- the magnetic particles and the at least one central element are advantageously arranged in a closed vessel.
- the added volume V m of the magnetic particles and that of the at least one central element are 0 0.25% to 50 50% of the total volume V G of the vessel. This has proven to be favorable for many applications.
- the added volume V m of the magnetic particles and that of the at least one central element are preferably 0 0.5% to 20 20%, even more preferably 1 1% to 15 15%, of the total volume V G of the vessel.
- the device according to the invention further comprises at least one external magnet which is designed to interact with the at least one central element.
- the central element is a permanent magnet
- the ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is according to a preferred embodiment of the invention H 3 ⁇ 1.1 ⁇ H 2 to H 3 ⁇ 10 ⁇ H 2
- the ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is advantageously H 3 1.5 1.5 ⁇ H 2 to H 3 8 8 ⁇ H 2 , even more preferably H 3 2 2 ⁇ H 2 to H 3 ⁇ 5 ⁇ H 2 .
- the at least one external magnet is and / or comprises an electromagnet (s) which is operated under alternating voltage for the homogenization of the magnetic particles.
- the central element is then preferably a (permanent) magnet.
- the at least one external magnet is and / or comprises a permanent magnet (s).
- the central element remains in the container throughout the process.
- step a) comprises resuspending the magnetic particles in the liquid.
- the magnetic particles were at least partially, preferably almost completely, attached to the at least one central element, and step a) takes place by the action of an external force on the at least one central element, which during the entire process the container remains.
- Step b) is advantageously supported by means of a further, external permanent magnet.
- a further, external permanent magnet is brought into the vicinity of the vessel in which the magnetic particles and the at least one central element are located.
- this allows the magnetic particles to be deposited on the at least one central element much more quickly.
- This embodiment has also proven to be particularly advantageous when the at least one central element is not a permanent magnet.
- the present invention also relates to the use of a device according to the invention and / or a method according to the invention for at least partial separation of biomolecules from / in a preferably aqueous solution.
- biomolecules all biomolecules, such as, for. B understood lipids, carbohydrates, metabolites, metabolic products, all types of nucleic acids, all types of peptides and proteins, also substituted or functionalized peptides and / or proteins.
- biomolecules is further understood - but not limited to this - to mean all molecules which occur naturally or are artificially introduced in biological samples.
- the device according to the invention and / or the method according to the invention is advantageously used for at least partial separation of nucleic acids from / in a preferably aqueous solution.
- nucleic acid in the sense of the present invention is particularly - but not limited to - natural, preferably isolated, linear, branched or circular nucleic acids such as RNA, in particular mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA or ribozymes, DNA and Similar, synthetic or modified nucleic acids, for example oligonucleotides, in particular primers, probes or standards used for the PCR, nucleic acids labeled with digoxigenin, biotin or fluorescent dyes or so-called PNAs ( “peptide nucleic acids ”) are understood.
- RNA in particular mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA or ribozymes, DNA and Similar, synthetic or modified nucleic acids, for example oligonucleotides, in particular primers, probes or standards used for the PCR, nucleic acids labeled with digoxigenin, biotin or fluorescent dyes or so-called PNAs
- Fig. 1 shows a very schematic view of a device according to the invention according to an embodiment. It should be noted that 1 and 2 are highly schematic and in most applications of the inventors the actual ratios (be it size ratios such as the number of magnetic particles) will be different.
- the device comprises a plurality of first magnetic particles 10 which are attached to a central element 20 in the “idle state”.
- Magnetic particles 10 and central magnet 20 are arranged in a (preferably closed) vessel 100, which can optionally have inlets and outlets 110 or 120 (indicated schematically in dashed lines).
- the vessel 100 is preferably filled with a liquid 150 to such an extent that the magnetic particles 10 and the central element 20 are in the liquid.
- the central element 20 is a permanent magnet; however, this is not limitative. As already described, the central element 20 can also contain a magnetizable material such as iron.
- Another embodiment for moving the at least one central element is a one-dimensional oscillating movement. Due to the effect of a magnetic field that moves back and forth on a line, the at least one central element is alternately “hewn” against the opposite vessel walls, as a result of which the magnetic particles are also effectively shaken off the central element 20.
- a shaking movement of the at least one central element can also take place by means of an electromagnet when it is operated under alternating voltage and the magnetic field polarity changes alternately, insofar this also represents a preferred embodiment of the invention. If the operating mode is changed to direct current, a magnetic separation takes place.
- the magnetic particles 10 attach themselves to the central element 20 again, so that (essentially) the state of the Fig. 1 is reached again.
- the liquid 150 can now be removed from the vessel, for example, or additional reagents can be added, depending on the specific application.
- the present example is also to be understood in a purely illustrative manner with regard to the size / volume / quantity information described or the geometric design of the reaction vessel.
- the present invention can be applied within a wide range and a person skilled in the art will accordingly choose other dimensions or arrangements.
- the option to design this as an open system see example I.
- the present invention also applies to Microsystems, such as micromixers etc., can be used very well in many applications, which is a preferred embodiment of the present invention.
- Genomic DNA was isolated from 5 ml of whole blood using the following protocol: 5 ml of blood was placed in a 30 ml beaker with a central element (standard Teflon-coated stirring fish; length 2 cm; diameter 7 mm).
- Buffer AL brand product from QIAGEN
- QIAGEN Proteinase K
- An external magnetic stirrer was used for 5 min. stirred to bind the genomic DNA to the magnetic particles.
- the supernatant was removed again and 15 ml of washing buffer AW2 (QIAGEN) were added.
- the magnetic particles were then homogenized by stirring for 60 seconds. After the stirring had stopped, the magnetic particles were deposited on the central element.
- the supernatant was removed, then the magnetic particles were air dried for 20 min.
- Buffer TE DNA Elution, QIAGEN
- the UV curve of the supernatant is in Fig. 3 to see.
- the yield can be estimated on the basis of the UV spectrum, which took place approximately quantitatively in Example 1 (approx. 170 ⁇ g genomic DNA from 5 ml whole blood).
Landscapes
- Physical Or Chemical Processes And Apparatus (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Claims (12)
- Dispositif de traitement d'un liquide comportant des particules magnétiques, ledit dispositif comprenant un récipient (100), qui contient le liquide (150), et une multitude de particules magnétiques (10) disposées dans le liquide (150) ainsi qu'au moins un élément central magnétique et/ou magnétisable (20) en forme de tige, d'haltère ou d'ellipsoïde, le rapport du plus long diamètre d2 de l'au moins un élément central (20) au diamètre moyen d1 des particules magnétiques (10) étant d'au moins
le dispositif comprenant en outre au moins un aimant externe qui est conçu pour interagir avec l'au moins un élément central (20) de sorte que l'élément central (20) peut être déplacé par l'aimant externe. - Dispositif selon la revendication 1, le nombre de particules magnétiques (10) par élément central (20) étant ≥ 104.
- Dispositif selon l'une des revendications 1 à 3, les particules magnétiques (10) contenant un matériau choisi dans le groupe comprenant les matériaux paramagnétiques, les matériaux superparamagnétiques, les matériaux ferromagnétiques, les matériaux ferrimagnétiques et leurs mélanges.
- Dispositif selon l'une des revendications 1 à 4, le volume ajouté Vm des particules magnétiques (10) ainsi que l'au moins un élément central (20) étant ≥ 0,25 % à ≤ 50 % du volume total VG du récipient (100).
- Dispositif selon l'une des revendications 1 à 5, l'élément central (20) comprenant au moins un aimant permanent et le rapport de la force magnétique H3 de l'au moins un aimant externe à la force magnétique H2 de l'au moins un élément central (20) étant
H3 ≥ 1, 1∗H2 à H3 ≤ 10∗H2. - Dispositif selon l'une des revendications 1 à 6, l'au moins un aimant externe étant un électroaimant.
- Dispositif selon l'une des revendications 1 à 6, l'au moins un aimant externe étant un aimant permanent.
- Procédé de traitement de liquides comportant des particules magnétiques (10) à l'aide d'un dispositif selon l'une des revendications 1 à 8, le procédé comprenant les étapes suivantes :a) répartir les particules magnétiques (10) dans le liquide (150) puisb) fixer les particules magnétiques (10) à l'au moins un élément central (20).
- Procédé selon la revendication 9, caractérisé en ce que l'étape a) comprend une remise en suspension des particules magnétiques (10) dans le liquide (150).
- Procédé selon la revendication 9 ou 10, caractérisé en ce que, avant l'étape a), les particules magnétiques (10) étaient fixées au moins partiellement à l'au moins un élément central (20) et l'étape a) est effectuée par action d'une force sur l'au moins un élément central (20).
- Utilisation d'un dispositif selon l'une des revendications 1 à 8 et/ou d'un procédé selon l'une des revendications 9 à 11 pour séparer au moins partiellement des biomolécules d'une/dans une solution de préférence aqueuse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007045474A DE102007045474A1 (de) | 2007-09-21 | 2007-09-21 | Vorrichtung und Verfahren zum Behandeln von Flüssigkeiten mit magnetischen Partikeln |
PCT/EP2008/062539 WO2009040312A1 (fr) | 2007-09-21 | 2008-09-19 | Dispositif et procédé de traitement de liquides avec des particules magnétiques |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2192987A1 EP2192987A1 (fr) | 2010-06-09 |
EP2192987B1 true EP2192987B1 (fr) | 2020-04-22 |
Family
ID=40350080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08804473.0A Active EP2192987B1 (fr) | 2007-09-21 | 2008-09-19 | Dispositif et procédé de traitement de liquides avec des particules magnétiques |
Country Status (5)
Country | Link |
---|---|
US (1) | US8361326B2 (fr) |
EP (1) | EP2192987B1 (fr) |
JP (1) | JP5336495B2 (fr) |
DE (1) | DE102007045474A1 (fr) |
WO (1) | WO2009040312A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2574931B1 (fr) | 2011-09-29 | 2017-03-22 | Qiagen GmbH | Composition sèche comprenant un colorant de contrôle |
EP2766493B1 (fr) | 2011-10-11 | 2019-12-18 | Qiagen GmbH | Procédé de traitement d'échantillons et cartouche de traitement d'échantillons |
JP2015159733A (ja) * | 2014-02-26 | 2015-09-07 | セイコーエプソン株式会社 | 物質結合用固相担体の凍結乾燥体、物質含有液中の物質を物質結合用固相担体と結合させるための容器、および、物質結合用固相担体を含む凍結乾燥体の製造方法 |
US10711265B2 (en) | 2015-06-01 | 2020-07-14 | Qiagen Gmbh | Electrophoresis assisted method for purifying a target nucleic acid using a delayed elution approach |
EP3303582A1 (fr) | 2015-06-01 | 2018-04-11 | Qiagen GmbH | Procédé assisté par électrophorèse et dispositif de purification d'une molécule cible chargées à partir d'un échantillon |
KR101834828B1 (ko) | 2017-06-02 | 2018-03-07 | 한국과학기술원 | 자력을 이용한 세균 농축방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072531A1 (fr) * | 2002-02-01 | 2003-09-04 | Exportech Company, Inc. | Procede et appareil pour recuperer des particules magnetiques dans un reacteur a phase de suspension |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8400855A (nl) | 1984-03-16 | 1985-10-16 | Wagemans Maastricht B V | Verend scharnier. |
JPH04102062A (ja) * | 1990-08-22 | 1992-04-03 | Hitachi Ltd | 粒子免疫側定法 |
US5897783A (en) * | 1992-09-24 | 1999-04-27 | Amersham International Plc | Magnetic separation method |
DE4423878A1 (de) | 1994-07-07 | 1996-01-11 | Boehringer Mannheim Gmbh | Vorrichtung und Verfahren zum Abscheiden von magnetischen Mikropartikeln |
FI944939A0 (fi) * | 1994-10-20 | 1994-10-20 | Labsystems Oy | Foerfarande foer separering av partiklar |
FI944940A0 (fi) | 1994-10-20 | 1994-10-20 | Labsystems Oy | Tvaofasigt separeringsfoerfarande |
WO1997044671A1 (fr) | 1996-05-20 | 1997-11-27 | Precision System Science Co., Ltd. | Procede et appareil pour commander des particules magnetiques a l'aide d'une machine de pipettage |
EP1712921A2 (fr) | 1997-09-29 | 2006-10-18 | F.Hoffmann-La Roche Ag | Appareil de séparation des particules magnétiques |
FI102906B (fi) | 1998-02-23 | 1999-03-15 | Bio Nobile Oy | Menetelmä ja väline aineen siirtämiseksi |
FI20000583A0 (fi) | 2000-03-14 | 2000-03-14 | Labsystems Oy | Astia ja sauva |
FI120863B (fi) * | 2002-10-18 | 2010-04-15 | Biocontrol Systems Inc | Magneettinen siirtomenetelmä ja mikropartikkelien siirtolaite |
DE10331254B4 (de) * | 2003-07-10 | 2006-05-04 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Vorrichtung und Verfahren zum Abtrennen von magnetischen oder magnetisierbaren Partikeln aus einer Flüssigkeit |
FI20051248L (fi) | 2005-12-02 | 2007-06-03 | Bio Nobile Oy | Biologisten komponenttien rikastusyksikkö ja rikastusmenetelmä |
-
2007
- 2007-09-21 DE DE102007045474A patent/DE102007045474A1/de not_active Withdrawn
-
2008
- 2008-09-19 EP EP08804473.0A patent/EP2192987B1/fr active Active
- 2008-09-19 US US12/676,376 patent/US8361326B2/en active Active
- 2008-09-19 WO PCT/EP2008/062539 patent/WO2009040312A1/fr active Application Filing
- 2008-09-19 JP JP2010525360A patent/JP5336495B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072531A1 (fr) * | 2002-02-01 | 2003-09-04 | Exportech Company, Inc. | Procede et appareil pour recuperer des particules magnetiques dans un reacteur a phase de suspension |
Also Published As
Publication number | Publication date |
---|---|
US8361326B2 (en) | 2013-01-29 |
JP2010539502A (ja) | 2010-12-16 |
EP2192987A1 (fr) | 2010-06-09 |
DE102007045474A1 (de) | 2009-04-02 |
US20100307981A1 (en) | 2010-12-09 |
WO2009040312A1 (fr) | 2009-04-02 |
JP5336495B2 (ja) | 2013-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1446668B1 (fr) | Dispositif et procede de traitement de particules magnetiques | |
EP2033715B1 (fr) | Procédé destiné à suspendre ou resuspendre des particules dans une solution et dispositif adapté | |
EP1919625B1 (fr) | Dispositif et procede de separation de particules magnetiques d'un liquide | |
EP1843854B1 (fr) | Procede et dispositif pour separer des particules magnetiques ou magnétisables d'un liquide | |
EP1644120B1 (fr) | Dispositif et procede pour extraire d'un liquide des particules magnetiques ou magnetisables | |
EP2192987B1 (fr) | Dispositif et procédé de traitement de liquides avec des particules magnétiques | |
EP1420888B1 (fr) | Systeme destine a la separation de particules pouvant etre attirees magnetiquement | |
DE102006002258B4 (de) | Modul zur Aufbereitung einer biologischen Probe, Biochip-Satz und Verwendung des Moduls | |
DE10057396C1 (de) | Verfahren zum Abtrennen eines dispergierten oder gelösten Stoffes und Magnetseparator | |
DE60207564T2 (de) | Behandlungsverfahren für magnetische teilchen und bioanalyse-apparat mit magnetverwendung | |
DE60023185T2 (de) | Apparat und verfahren zum mischen und trennen unter benützung magnetischer teilchen | |
WO2018167138A1 (fr) | Procédé d'enrichissement de cellules à partir d'un échantillon et d'isolement consécutif de l'acide nucléique de ces cellules | |
EP3693739A1 (fr) | Procédé et dispositif d'isolation de cellules souhaitées d'un échantillon des matériaux biologiques non magnétiques | |
DE19854003A1 (de) | Simultanes Magnetpartikelhandling in zweidimensionaler Anordnung | |
DE112019004459T5 (de) | Anreicherung von proben mittels magnetischer partikel in mikrokanälen | |
EP3147028B1 (fr) | Procede et dispositif de separation magnetique de nanobilles | |
DE202021105458U1 (de) | Vorrichtung zur magnetischen Aufreinigung biologischer Proben | |
DE19955169A1 (de) | Verfahren und Vorrichtung zur Ausübung einer Kraft auf magnetische Partikel | |
EP3710163A1 (fr) | Dispositif et procédé d'immobilisation réversible de biomolécules | |
WO2024074205A1 (fr) | Récipient, dispositif de mélange et procédé d'utilisation d'un dispositif de mélange | |
WO2007000399A1 (fr) | Matiere de support et procede de fabrication et d'utilisation de ladite matiere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100421 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20130605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 502008017067 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: B03C0001280000 Ipc: B03C0001033000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B03C 1/01 20060101ALI20191219BHEP Ipc: B03C 1/033 20060101AFI20191219BHEP Ipc: B03C 1/28 20060101ALI20191219BHEP |
|
INTG | Intention to grant announced |
Effective date: 20200113 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008017067 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1259374 Country of ref document: AT Kind code of ref document: T Effective date: 20200515 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200824 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200822 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200723 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008017067 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20210125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1259374 Country of ref document: AT Kind code of ref document: T Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230920 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230928 Year of fee payment: 16 Ref country code: DE Payment date: 20230920 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230927 Year of fee payment: 16 |